Activation of the JAK/STAT Pathway Leads to BRAF Inhibitor Resistance in BRAFV600E Positive Thyroid CarcinomaJessica Limberg, Irene M. Min, Caitlin E. Egan et al.|Molecular Cancer Research|2023Cited by 24
Supplementary Tables 1-5 from Activation of the JAK/STAT Pathway Leads to BRAF Inhibitor Resistance in BRAF<sup>V600E</sup> Positive Thyroid CarcinomaJessica Limberg, Irene M. Min, Timothy M. Ullmann et al.|Unknown|2023Cited by 0
Supplementary Figures 1-7 from Activation of the JAK/STAT Pathway Leads to BRAF Inhibitor Resistance in BRAF<sup>V600E</sup> Positive Thyroid CarcinomaJessica Limberg, Irene M. Min, Caitlin E. Egan et al.|Unknown|2023Cited by 0
Supplementary Figures 1-7 from Activation of the JAK/STAT Pathway Leads to BRAF Inhibitor Resistance in BRAF<sup>V600E</sup> Positive Thyroid CarcinomaJessica Limberg, Irene M. Min, Caitlin E. Egan et al.|Unknown|2023Cited by 0
Supplementary Tables 1-5 from Activation of the JAK/STAT Pathway Leads to BRAF Inhibitor Resistance in BRAF<sup>V600E</sup> Positive Thyroid CarcinomaJessica Limberg, Irene M. Min, Caitlin E. Egan et al.|Unknown|2023Cited by 0